150 | Please don't forget to MARK THE BOARD !!! | stockstallion | 03/03/2012 9:55:59 PM |
680 | ATTENTION Investors/Traders: Looking for people | stockstallion | 10/16/2012 12:16:22 AM |
707 | LOOKING for CTLE to make a nice leap forward! | stockstallion | 12/16/2012 5:22:27 PM |
10 | Good morning to all here at | junewong | 02/20/2012 10:01:26 AM |
9 | Board Marked!!!!!!!!!!!!! | Godspeed | 02/20/2012 8:48:55 AM |
8 | Board Marked | bra1loga | 02/20/2012 8:08:50 AM |
7 | I have the same problem..can only work (and | junewong | 02/19/2012 6:01:55 PM |
6 | EMWW is on my radar next week. (Provided my | Roger Wilco | 02/19/2012 5:58:56 PM |
5 | sign up for board alerts,don't miss out on the | stockstallion | 02/19/2012 5:44:23 PM |
4 | EMWW..on high alert | junewong | 02/19/2012 5:41:23 PM |
3 | Nice board..marked | junewong | 02/19/2012 5:40:33 PM |
2 | HRAL is going to rock on Tuesday! | the outlaw | 02/19/2012 5:18:57 PM |
Recent Articles
- Santhera Pharmaceuticals Extends Maturity of Convertible Bonds
- KH Group's 2025 Half-Year Review: Performance Highlights and Insights
- Desert Control's Q2 Progress: Innovations and Financial Insights
- Desert Control: Progress and Financial Highlights in 2025
- Desert Control Celebrates Operational Success in Q2 2025 Update
- UnitedHealth Rises as Investors Burry and Buffett Back It
- AARP New York's 90-Year Celebration of Social Security Impact
- Tragic Encounter: Man's Fatal Meeting With Meta AI Disturbs Community
- Projected Surge in Data Center Infrastructure by 2029
- John Bolton Critiques Trump's Tariffs on Russian Oil and India
- Cynthia Lummis Advocates for Strategic Bitcoin Reserve Plan
- Propanc Biopharma Pursues Nasdaq Uplisting with New Offering
- Propanc Biopharma Secures Nasdaq Listing with Public Offering
- Key Insights on Top Stocks: Opendoor, Amazon, and More
- Sangfor Recognized for Innovation in SASE by Frost & Sullivan
- Yerba Madre Launches Exciting New Seasonal Flavor Watermelody
- Intel Corporation Sees Positive After-Hours Gains Amid Trends
- Bitcoin's Recent Decline and Future Market Predictions
- Robot Consulting's Fiscal Year 2025 Financial Insights
- Robot Consulting Co., Ltd. Reports FY 2025 Financial Update
- Transforming Industries: Saigon Technology's AI Solutions
- Marketing Maven Selected by LISC LA for Strategic Support
- Revolutionizing Library Services: Clarivate and University of Melbourne Collaboration
- Reflecting on Yucun's 20-Year Journey Towards Ecological Success
- Innovative Partnership Between Clarivate and University of Melbourne
- Unitil Corporation Announces Exciting Common Stock Offering
- Cathie Wood Makes Bold Moves: Major Investments in Deere, Block, and Robinhood
- Unitil Corporation's New Stock Offering: What Investors Should Know
- Investors Urged to Act Amid Altimmune Class Action Concerns
- James Lukezic Addresses FINRA Investigation Challenges
- Exploring Deqing: A Thrilling Journey through Zhejiang
- Breach of Trust: Jane Doe 100's Legal Stand Against OBGYN
- LIXTE Biotech's Innovative Trials Set for Major 2025 Milestones
- Jiin Ming Launches Innovative UAV Solutions at TADTE 2025
- Investigation Into LifeCore Biomedical's Practices Escalates
- CS Disco Faces Investigation as Shareholder Rights Are Questioned
- Light AI Inc. Shares Progress in Financial Performance Update
- Ammunition Market Growth Trends and Key Players Overview
- Investigation Into Venture Global, Inc. for Long-Term Shareholders
- EnWave Sets Date for Upcoming Financial Report and Call
- Visa Inc. Faces Investigation from Shareholder Rights Law Firm
- Zeta Global Holdings Facing Legal Scrutiny Amid Shareholder Concerns
- EnWave Corporation's Q3 Results Announcement and Call Details
- Investigating Inspirato Inc: Shareholder Rights and Options
- CARsgen Therapeutics Unveils Strong Interim Results for 2025
- Bonterra Energy Reports Impressive Q2 2025 Financial Results
- Lockheed Martin Investors May Pursue Class Action Lawsuit
- Understanding Your Rights: Luminar Technologies Securities Case
- Exploring SIGGRAPH 2025: Innovation in Computer Graphics
- CARsgen Therapeutics Reports Promising Interim Results for 2025